CLINICAL TRIALS OFFICE
FIND A STUDY
Be a Study Participant
There are many ways to find out about clinical trials conducted at LSU Healthcare Network and LSU Health Science Center. Most people ask their doctor or the health professional whom they see most often. Other people actively look for clinical trials online or in other places, hoping to find more options for treatment.
How can you participate in a clinical trial?
Those interested in volunteering for a study are encouraged to browse below for all the trial open to recruitment at LSU Healthcare Network.
You can also visit the National Institutes of Health (NIH) website which has an even larger database of clinical trials.
What happens when you contact us?
During the study screening, our clinical research staff will briefly explain the study and discuss the risk and benefits of participating in the study. You will be asked a few questions to determine your eligibility to take part in the study. If you eligible, you will be aske to visit the clinic for a physical examination and completion of any required enrollment documentation. If you are not eligible, you can contact our team in the future if other trials are available.
Active Trials at LSU Healthcare Network
TITAN 2 : Now Recruiting
Eligibility: 18 years of age or older Principal Investigator: Ryan Krlin, MD
Condition: Overactive Bladder IRB Number: 2131
Intervention: Device: Medtronic Implantable
Tibial Neuromodulation (TNM) System
Cycling Study: Now Recruiting
Eligibility: 18 years of age or older Principal Investigator: Ryan Krlin, MD
Condition: Overactive Bladder Syndrome IRB Number: 4577
Intervention: Device: Axonics System
PEER 2: Now Recruiting
Eligibility: 18 years of age or older Principal Investigator: Ryan Krlin, MD
Condition: Overactive Bladder IRB Number: 2119
Intervention: Device: Sacral Neuromodulation
DeepView Snapshot Portable: Now Recruiting
Eligibility: Child, Adult, Older Adult Principal Investigator: Herbert Phelan, MD
Condition: Burns, Wound Heal IRB Number: 1957
Intervention: Device: DeepView SnapShotPortable (DV-SSP)
Skingenix MW-III-BURN-2-001: Now Recruiting
Eligibility: Child, Adult, Older Adult Principal Investigator: Herbert Phelan, MD
Condition: Burns IRB Number: 2300
Intervention: Drug: Investigational Drug, MW-III
Drug: Silvadene® Cream 1% [Silver Sulfadiazine]